C. Bupp

Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes.

M. Pasquini, Stephanie J. Lee, B. Shaw, 2022, Transplantation and cellular therapy.

One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors

N. Kröger, J. Snowden, H. Baldomero, 2021, Haematologica.

Non-infectious pulmonary toxicity after allogeneic hematopoietic cell transplantation.

M. Sorror, M. Krem, M. Pasquini, 2022, Transplantation and cellular therapy.

Expanded HCT-CI Definitions Capture Comorbidity Better for Younger Patients of Allogeneic HCT for Non-Malignant Diseases

M. Sorror, E. Guinan, M. Krem, 2022, Transplantation and Cellular Therapy.

Real-world data showing trends and outcomes by race and ethnicity in allogeneic hematopoietic cell transplantation: a report from the Center for International Blood and Marrow Transplant Research.

M. Pasquini, B. Shaw, K. Flynn, 2023, Transplantation and cellular therapy.

Differential use of the hematopoietic cell transplantation-comorbidity index among adult and pediatric transplant physicians

M. Sorror, M. Pasquini, M. Thakar, 2022, Leukemia & lymphoma.

Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation.

M. Sorror, M. Krem, M. Pasquini, 2022, Transplantation and Cellular Therapy.